| abstract |
The present invention relates to a novel method for monitoring and inducing therapeutic suppression of parathyroid hormone in renal patients with secondary hyperparathyroidism. Determine and monitor the levels of parathyroid hormone agonists and parathyroid hormone antagonists in renal patients. The parathyroid hormone inhibitory therapeutic is administered to the patient to minimize the level of parathyroid hormone antagonist. In one embodiment, a method is provided for monitoring and managing therapeutic suppression of parathyroid hormone in a renal patient suffering from late hyperparathyroidism. |